<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: FDA Puts Black Box On Avandia For Heart Attacks</title>
	<atom:link href="http://www.pharmalot.com/2007/11/fda-puts-black-box-on-avandia-for-heart-attacks/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2007/11/fda-puts-black-box-on-avandia-for-heart-attacks/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 20:58:31 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Tom Lamb</title>
		<link>http://www.pharmalot.com/2007/11/fda-puts-black-box-on-avandia-for-heart-attacks/#comment-25918</link>
		<dc:creator>Tom Lamb</dc:creator>
		<pubDate>Thu, 15 Nov 2007 00:35:50 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2007/11/fda-puts-black-box-on-avandia-for-heart-attacks/#comment-25918</guid>
		<description>One wonders whether GlaxoSmithKline might do a "soft" recall of its embattled diabetes drug Avandia -- as was done by Bristol-Myers Squibb with Serzone and Tequin In recent years?  For more discussion of this idea, see:

http://www.drug-injury.com/druginjurycom/2007/11/will-new-black-.html</description>
		<content:encoded><![CDATA[<p>One wonders whether GlaxoSmithKline might do a &#8220;soft&#8221; recall of its embattled diabetes drug Avandia &#8212; as was done by Bristol-Myers Squibb with Serzone and Tequin In recent years?  For more discussion of this idea, see:</p>
<p><a href="http://www.drug-injury.com/druginjurycom/2007/11/will-new-black-.html" rel="nofollow">http://www.drug-injury.com/druginjurycom/2007/11/will-new-black-.html</a></p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.151 seconds -->

